Full refunds apply only to unopened products
Journal of Medical Economics
Both figures exceed the 20.9% mean weight loss seen with semaglutide 2.4 mg at 68 weeks in STEP-1 (N=1,961) [6], and the 22.5% seen with tirzepatide 15 mg at 72 weeks in SURMOUNT-1 (N=2,539) [7]
He has spent a lifetime, a career, dealing with this issue, and having him on our podcast is a privilege, and actually, I hope our listeners understand the amount of intelligence and feedback that he has provided, how important that is, because at the end of the day, he knows FDA better than anyone else
Providers dont typically recommend using prescription sleeping pills long term because theyre not a cure for insomnia and theres a risk of dependence and addiction